SB-1436 is used in neurological disease research due to its ability to significantly inhibit Aβ self-aggregation; it acts as a cholinesterase (ChE) inhibitor, showing inhibitory activity against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and recombinant human acetylcholinesterase (rHuAChE).